{"title":"Sample","authors":"Sam Sample","doi":"10.5455/im.20181230061723","DOIUrl":null,"url":null,"abstract":"Sample Age at dx WBC Marrow FAB Cytogenetics Treatment Response to Followup Status Cause Constit. (in years) (x10 /μL) Blast % Protocol Course 1 (days) of Death pStat3 CBF 1 13.2 24.3 51 M2 45,X,-Y,t(8:21)(q22:q22)[14]/46,XY[6] CCG 2961 W/D (NR) 1569 Alive CBF 2 3.8 19.8 32 M2 45,X,-X,t(8:21)(q22:q22)[19]/46,XX[1] CCG 2961 CR 3629 Alive CBF 3 12.9 69.2 73 M2 46,XX,der(7)t(7:9)(q22:q13),t(8:21)(q22:q22), CCG 2961 CR 485 Dead PD add(9)(q13)[20] CBF 4 15.1 7.9 7 Unk 45,X,-Y,t(8;21)(q22;q22)[20] AAML03P1 CR 1634 Alive + CBF 5 4.0 5.7 77 M2 46,XX,t(8;21)(q22;q22) AAML03P1 CR 1197 Alive CBF 6 11.1 19.7 85 M2 45,X,-Y,t(8:21)(q22:q22)[18]/46,XY[2] CCG 2961 CR 4013 Alive CBF 7 4.2 38 59 M2 46,XY,t(8:16:21)(q22:p11.2:q22)[8]/46, CCG 2961 CR 3754 Alive idem,der(9)t(1:9)(q25:q34)[20]/46,XY[2] CBF 8 11.5 31.8 28 M2 46,XX,t(8:21)(q22:q22)[20] CCG 2961 CR 451 Dead Infection CBF 9 11.7 14 72 M2 45,X,-X,t(8:21)(q22:q22)[20] CCG 2961 W/D (CR) 2432 Alive CBF 10 16.2 25.4 85 M2 46,XY,t(8:21)(q22:q22)[20] CCG 2961 CR 2319 Alive -","PeriodicalId":11543,"journal":{"name":"Encyclopedic Dictionary of Archaeology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"127","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Encyclopedic Dictionary of Archaeology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/im.20181230061723","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 127
Abstract
Sample Age at dx WBC Marrow FAB Cytogenetics Treatment Response to Followup Status Cause Constit. (in years) (x10 /μL) Blast % Protocol Course 1 (days) of Death pStat3 CBF 1 13.2 24.3 51 M2 45,X,-Y,t(8:21)(q22:q22)[14]/46,XY[6] CCG 2961 W/D (NR) 1569 Alive CBF 2 3.8 19.8 32 M2 45,X,-X,t(8:21)(q22:q22)[19]/46,XX[1] CCG 2961 CR 3629 Alive CBF 3 12.9 69.2 73 M2 46,XX,der(7)t(7:9)(q22:q13),t(8:21)(q22:q22), CCG 2961 CR 485 Dead PD add(9)(q13)[20] CBF 4 15.1 7.9 7 Unk 45,X,-Y,t(8;21)(q22;q22)[20] AAML03P1 CR 1634 Alive + CBF 5 4.0 5.7 77 M2 46,XX,t(8;21)(q22;q22) AAML03P1 CR 1197 Alive CBF 6 11.1 19.7 85 M2 45,X,-Y,t(8:21)(q22:q22)[18]/46,XY[2] CCG 2961 CR 4013 Alive CBF 7 4.2 38 59 M2 46,XY,t(8:16:21)(q22:p11.2:q22)[8]/46, CCG 2961 CR 3754 Alive idem,der(9)t(1:9)(q25:q34)[20]/46,XY[2] CBF 8 11.5 31.8 28 M2 46,XX,t(8:21)(q22:q22)[20] CCG 2961 CR 451 Dead Infection CBF 9 11.7 14 72 M2 45,X,-X,t(8:21)(q22:q22)[20] CCG 2961 W/D (CR) 2432 Alive CBF 10 16.2 25.4 85 M2 46,XY,t(8:21)(q22:q22)[20] CCG 2961 CR 2319 Alive -
样本
样本年龄在dx WBC骨髓FAB细胞遗传学治疗对随访状态的反应。(年)(x10 /μL) Blast % Protocol病程1(天)死亡pStat3 CBF 1 13.2 24.3 51 M2 45,X，-Y,t(8:21)(q22:q22)[14]/46,XY[6] CCG 2961 W/D (NR) 1569 Alive CBF 2 3.8 19.8 32 M2 45,X，-X,t(8:21)(q22:q22)[19]/46,XX[1] CCG 2961 CR 3629 Alive CBF 3 12.9 69.2 73 M2 46,XX,der(7)t(7:9)(q22:q13)，t(8:21)(q22:q22)，CCG 2961 CR 485 Dead PD add(9)(q13)[20] CBF 4 15.1 7.9 7 Unk 45,X，-Y,t(8;21)(q22;q22)[20] AAML03P1 CR 1634 Alive + CBF 5 4.0 5.7 77 M2 46,XX,t(8;21)(q22;q22) AAML03P1 CR 1197 Alive CBF 6 11.1 19.7 85 M2 45,X，-Y,t(8:21)(q22:q22)[18]/46,XY[2] CCG 2961 CR 4013 Alive CBF 7 4.2 38 59 M2 46,XY,t(8:16:21)(q22:p11.2:q22)[8]/46，CCG 2961 CR 3754 Alive idem,der(9)t(1:9)(q25:q34)[20]/46,XY[2] CBF 8 11.5 31.8 28 M2 46,XX,t(8:21)(q22:q22)[20] CCG 2961 CR 451 Dead Infection CBF 9 11.7 14 72 M2 45,X，-X,t(8:21)(q22:q22)[20] CCG 2961 W/D (CR) 2432 Alive CBF 10 16.2 25.4 85 M2 46,XY,t(8:21)(q22:q22)[20] CCG 2961 CR 2319 Alive -
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
